JPWO2022211537A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022211537A5 JPWO2022211537A5 JP2023555563A JP2023555563A JPWO2022211537A5 JP WO2022211537 A5 JPWO2022211537 A5 JP WO2022211537A5 JP 2023555563 A JP2023555563 A JP 2023555563A JP 2023555563 A JP2023555563 A JP 2023555563A JP WO2022211537 A5 JPWO2022211537 A5 JP WO2022211537A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20210042305 | 2021-03-31 | ||
| KR10-2021-0042305 | 2021-03-31 | ||
| PCT/KR2022/004620 WO2022211537A1 (ko) | 2021-03-31 | 2022-03-31 | 신규한 면역 활성 인터루킨 2 아날로그 결합체 및 이의 제조 방법 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024512418A JP2024512418A (ja) | 2024-03-19 |
| JP2024512418A5 JP2024512418A5 (https=) | 2025-04-10 |
| JPWO2022211537A5 true JPWO2022211537A5 (https=) | 2025-04-10 |
Family
ID=83459706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023555563A Pending JP2024512418A (ja) | 2021-03-31 | 2022-03-31 | 新規な免疫活性インターロイキン２アナログ結合体及びその製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12599675B2 (https=) |
| EP (1) | EP4316528A4 (https=) |
| JP (1) | JP2024512418A (https=) |
| KR (2) | KR102680146B1 (https=) |
| CN (1) | CN116916969A (https=) |
| AR (1) | AR125263A1 (https=) |
| AU (1) | AU2022209248B2 (https=) |
| BR (1) | BR112023018530A2 (https=) |
| CA (1) | CA3205058C (https=) |
| CL (1) | CL2023002504A1 (https=) |
| IL (1) | IL304365B2 (https=) |
| MX (1) | MX2023010926A (https=) |
| PE (1) | PE20250672A1 (https=) |
| WO (1) | WO2022211537A1 (https=) |
| ZA (1) | ZA202307219B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022009123A1 (en) * | 2020-07-09 | 2022-01-13 | Eutilex Co., Ltd. | Il-2 variants |
| AU2023408268A1 (en) | 2022-12-23 | 2025-07-10 | Hanmi Pharm. Co., Ltd. | Formulations comprising immune stimulating IL-2 analog conjugates |
| KR20240137492A (ko) * | 2023-03-07 | 2024-09-20 | 한미약품 주식회사 | 암의 예방 또는 치료를 위한 인터루킨 2 아날로그 또는 이의 결합체 및 면역관문 억제제의 병용 요법 |
| JP2026509259A (ja) * | 2023-03-07 | 2026-03-17 | ハンミ ファーマシューティカル カンパニー リミテッド | インターロイキン２アナログ又はその結合体を含む癌予防又は治療用薬学的組成物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| JP4046354B2 (ja) | 1996-03-18 | 2008-02-13 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 増大した半減期を有する免疫グロブリン様ドメイン |
| KR100507796B1 (ko) * | 2003-04-03 | 2005-08-17 | 한미약품 주식회사 | 생체내 반감기가 증가된 ｐｅｇ-생리활성 폴리펩티드 동종이량체 결합체 및 이의 제조방법 |
| HUE029139T2 (hu) * | 2011-02-10 | 2017-02-28 | Roche Glycart Ag | Mutáns interleukin-2 polipeptidek |
| MX385194B (es) * | 2014-02-21 | 2025-03-14 | Nektar Therapeutics India Pvt Ltd | Agonistas il-2rbeta-selectivos en combinación con un anticuerpo anti-ctla-4 o un anticuerpo anti-pd-1. |
| GB2538666A (en) | 2014-07-21 | 2016-11-23 | Delinia Inc | Molecules that selectively activate regulatory T cells for the treatment of autoimmune diseases |
| EP3943101A1 (en) | 2014-10-21 | 2022-01-26 | SciClone Pharmaceuticals International Ltd. | Treatment of cancer with immune stimulator alpha thymosin peptide |
| WO2017052329A1 (en) * | 2015-09-24 | 2017-03-30 | Hanmi Pharm. Co., Ltd. | Protein complex by use of a specific site of an immunoglobulin fragment for linkage |
| KR102687530B1 (ko) | 2016-05-04 | 2024-07-25 | 암젠 인크 | T-조절 세포의 증식을 위한 인터류킨-2 뮤테인 |
| MX386014B (es) * | 2016-08-10 | 2025-03-18 | Univ Ajou Ind Academic Coop Found | Citocina fusionada a fc heterodimérico, y composición farmacéutica que comprende la misma. |
| US11077172B2 (en) * | 2016-11-08 | 2021-08-03 | Delinia, Inc. | IL-2 variants for the treatment of psoriasis |
| US20200299349A1 (en) * | 2017-11-21 | 2020-09-24 | The Board Of Trustees Of The Leland Stanford Junior University | Partial agonists of interleukin-2 |
| WO2019185705A1 (en) * | 2018-03-28 | 2019-10-03 | Ascendis Pharma A/S | Il-2 conjugates |
| MX2021000801A (es) * | 2018-07-24 | 2021-04-12 | BioNTech SE | Agonistas de il2. |
| WO2020057646A1 (zh) * | 2018-09-21 | 2020-03-26 | 信达生物制药(苏州)有限公司 | 新型白介素2及其用途 |
| US20220025007A1 (en) * | 2018-12-21 | 2022-01-27 | Hanmi Pharm. Co., Ltd. | Novel immunosuppressive interleukin 2 |
| TW202115105A (zh) | 2019-06-24 | 2021-04-16 | 德商拜恩迪克Ｒｎａ製藥有限公司 | Ｉｌ２激動劑 |
| KR20220044534A (ko) * | 2019-08-13 | 2022-04-08 | 엘피스 바이오파마슈티컬즈 | 조작된 인터류킨-2 수용체 베타 효능제 |
-
2022
- 2022-03-30 IL IL304365A patent/IL304365B2/en unknown
- 2022-03-31 EP EP22781656.8A patent/EP4316528A4/en active Pending
- 2022-03-31 BR BR112023018530A patent/BR112023018530A2/pt unknown
- 2022-03-31 AU AU2022209248A patent/AU2022209248B2/en active Active
- 2022-03-31 AR ARP220100795A patent/AR125263A1/es unknown
- 2022-03-31 KR KR1020220040626A patent/KR102680146B1/ko active Active
- 2022-03-31 US US18/000,096 patent/US12599675B2/en active Active
- 2022-03-31 PE PE2023002484A patent/PE20250672A1/es unknown
- 2022-03-31 MX MX2023010926A patent/MX2023010926A/es unknown
- 2022-03-31 WO PCT/KR2022/004620 patent/WO2022211537A1/ko not_active Ceased
- 2022-03-31 CN CN202280017977.7A patent/CN116916969A/zh active Pending
- 2022-03-31 JP JP2023555563A patent/JP2024512418A/ja active Pending
- 2022-03-31 CA CA3205058A patent/CA3205058C/en active Active
-
2023
- 2023-07-19 ZA ZA2023/07219A patent/ZA202307219B/en unknown
- 2023-08-24 CL CL2023002504A patent/CL2023002504A1/es unknown
-
2024
- 2024-06-14 KR KR1020240077657A patent/KR20240099117A/ko active Pending